Is admission blood glucose concentration a more powerful predictor of mortality after myocardial infarction than diabetes diagnosis? A retrospective cohort study

BMJ Open

Volumn 2, Issue 5, 2012, Pages

  Gholap, Nitin Narayan ^a   Mehta, Rajnikant Laxmishanker ^a   Ng, Leong ^a,b   Davies, Melanie J ^a   Khunti, Kamlesh ^a   Squire, Iain B ^a,b  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b GLENFIELD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ADULT; AGED; ARTICLE; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HUMAN; INDEPENDENT VARIABLE; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

EID: 84869823955     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2012-001596     Document Type: Article

References (27)

1. Malmberg K, Yusuf S, Gerstein HC, et al. Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS Registry. Circulation 2000;102:1014-19.
2. McGuire DK, Emanuelsson H, Granger CB, et al. Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes. Findings from the GUSTO IIb study. Eur Heart J 2000;21:1750-8.
3. Svensson A-M, McGuire DK, Abrahamsson P, et al. Association between hyper- and hypoglycaemia and 2-year all-cause mortality risk in diabetic patients with acute coronary events. Eur Heart J 2005;26:1255-61.
4. Capes SE, Hunt D, Malmberg K, et al. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000;355:773-8.
5. Wahab NN, Cowden EA, Pearce NJ, et al. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? J Am Coll Cardiol 2002;40:1748-54.
6. Kosiborod M, Rathore SS, Inzucchi SE, et al. Admission glucose and mortality in elderly patients hospitalised with acute myocardial infarction. Circulation 2005;111:3078-86.
7. Cao JJ, Hudson M, Jankowski M, et al. Relation of chronic and acute glycaemic control on mortality in acute myocardial infarction with diabetes mellitus. Am J Cardiol 2005;96:183-6.
8. Sinnaeve PR, Steg G, Fox KAA, et al. Association of fasting glucose with increased short-term and 6-month mortality in ST-elevation and non ST-elevation acute coronary syndromes. Arch Int Med 2009;169:402-9.
9. Squire IB, Nelson CP, Ng LL, et al. Prognostic value of admission blood glucose concentration and diabetes diagnosis on survival after acute myocardial infarction; results from 4702 index cases in routine practice. Clin Sci (London) 2010;118:527-35.
10. Ceriello A. Acute hyperglycaemia: a new risk factor during myocardial infarction. Eur Heart J 2001;26:328-31.
11. De Caterina R, Madonna R, Sourij H, et al. Glycaemia control in acute coronary syndromes: prognostic value and therapeutic options. Eur Heart J 2010;31:1557-64.
12. Ghoyal A, Mahaffey KW, Garg J, et al. Prognostic significance of the change in glucose level in the first 24h after acute myocardial infarction: results from the CARDINAL study. Eur Heart J 2006;27:1289-97.
13. Norhammar AM, Ryden L, Malmberg K. Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in non-diabetic patients. Diabetes Care 1999;22:1827-31.
14. Weston C, Walker L, Birkhead J. Early impact of insulin treatment on mortality for hyperglycaemic patients without known diabetes who present with an acute coronary syndrome. Heart 2007;93:1542-6.
15. Schnell O, Schafer O, Kleybrink S, et al. Intensification of therapeutic approaches reduces mortality in diabetic patients with acute myocardial infarction: the Munich registry. Diabetes Care 2004;27:455-60.
16. Malmberg K, Ryden L, Efendic S, et al. Randomised trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol 1995;26:57-65.
17. Malmberg K, Ryden L, Wedel H, et al., DIGAMI 2 Investigators. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J 2005;26:650-61.
18. Herrett E, Smeeth L, Walker L, et al. MINAP Academic group. The Myocardial Ischaemia National Audit Project (MINAP). Heart 2010;96:1264-7.
19. Blackledge HM, Newton J, Squire IB. Prognosis for South Asian and white patients newly admitted to hospital with heart failure in the United Kingdom: historical cohort study. BMJ 2003;327:526-31.
20. Thygesen K, Alpert JS, White HD. The Joint ESC/ACCF/AHA/WHF Task Force for the redefinition of myocardial infarction. Eur Heart J 2007;28:2525-38.
21. Kosiborod M, Inzucchi SE, Krumholz HM, et al. Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk. Circulation 2008;117:1018.
22. Norhammar A, Tenerz A, Nilsson G, et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 2002;359:2140-4.
23. Tenerz A, Lonnberg I, Berne C, et al. Myocardial infarction and prevalence of diabetes mellitus, Is increased casual blood glucose at admission a reliable criterion for the diagnosis of diabetes? Eur Heart J 2001;22:1102-10.
24. De Mulder M, Oemrawsingh RH, Stam F, et al. Comparison of diagnostic criteria to detect undiagnosed diabetes in hyperglycaemiac patients with acute coronary syndrome. Heart 2012;98:37-41.
25. Melchior T, Kober L, Madsen CR, et al. Accelerating impact of diabetes mellitus on mortality in the years following an acute myocardial infarction. Eur Heart J 1999;20:973-8.
26. National Institute for Health and Clinical Excellence. Hyperglycaemia in acute coronary syndromes: management of hyperglycaemia in people with acute coronary syndromes (CG 130). London: National Institute for Health and Clinical Excellence, 2011.
27. Deedwania P, Kosibirod M, Barrett E, et al. Hyperglycaemia and acute coronary syndrome. A scientific Statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical activity and Metabolism. Circulation 2008;117:1610-19.